<DOC>
	<DOC>NCT01291173</DOC>
	<brief_summary>To evaluate the efficacy of SPD489 compared to placebo in the treatment of moderate to severe binge eating disorder as measured by the number of binge days per week</brief_summary>
	<brief_title>Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Feeding and Eating Disorders</mesh_term>
	<mesh_term>Binge-Eating Disorder</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Inclusion Subject meets the following Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Text Revision (DSMIVTR) criteria for a diagnosis of binge eating disorder (BED). Binge eating disorder is of at least moderate severity in which subjects report at least 3 binge eating days per week. Subject has a body mass index (BMI) of &gt;24 and &lt;46. Exclusion Subject has concurrent symptoms of bulimia nervosa or anorexia nervosa. Subject is considered a suicide risk or risk to harm others.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>